Synonym: 2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate hydrochloride hydrate; L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, monohydrochloride hydrate
CAS Number: 175865-59-5 (anhydrous)
Empirical Formula (Hill Notation): C14H22N6O5·HCl · xH2O
Molecular Weight: 390.82 (anhydrous basis)
Linear Formula: C14H22N6O5·HCl · xH2O
Product Type: Chemical
assay |
≥98% (HPLC) |
color |
white to tan |
form |
powder |
InChI |
1S/C14H22N6O5.ClH.H2O/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22;;/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22);1H;1H2/t8?,9-;;/m0../s1 |
InChI key |
XASVRRIYQZVANH-AHBBCRTASA-N |
originator |
Roche |
Quality Level |
100 |
SMILES string |
O.Cl.CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2C(=O)N=C(N)Nc12 |
solubility |
H2O: ≥8 mg/mL |
storage condition |
desiccated |
storage temp. |
−20°C |
Application: |
Valganciclovir hydrochloride hydrate may be used in HIV-related cell signaling studies. |
Biochem/physiol Actions: |
Valganciclovir hydrochloride hydrate is an antiviral used to treat cytomegalovirus infection. It is the prodrug of ganciclovir, a synthetic analog of 2′-deoxy-guanosine which is phosphorylated to a dGTP analog that competitively inhibits the incorporation of dGTP by viral DNA polymerase. |
Biochem/physiol Actions: |
Valganciclovir is a valine ester of Ganciclovir, used to treat cytomegalovirus retinitis in HIV-infected patients. It is rapidly metabolized to ganciclovir by hydrolysis before entering the systemic circulation resulting in improved absorption of the drug. |
Features and Benefits: |
This compound was developed by Roche . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Packaging: |
10, 50 mg in glass bottle |
RIDADR |
NONH for all modes of transport |
WGK Germany |
WGK 3 |
Flash Point(F) |
Not applicable |
Flash Point(C) |
Not applicable |
Purity |
≥98% (HPLC) |
Storage Temp. |
−20°C |
UNSPSC |
12352200 |